Unité de Fabrication des Médicaments S.A (BVMT:UMED)
Tunisia · Delayed Price · Currency is TND 8.95
+0.02 (0.22%)
At close: Sep 15, 2026
BVMT:UMED Ratios and Metrics
Market cap in millions TND. Fiscal year is January - December.
Millions TND. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 286 | 302 | 228 | 239 | 228 | 237 | |
Market Cap Growth | 5.54% | 32.54% | -4.68% | 5.06% | -3.91% | -24.00% |
Enterprise Value | 323 | 334 | 273 | 289 | 259 | 264 |
Last Close Price | 8.95 | 8.86 | 6.26 | 6.57 | 5.90 | 5.80 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 15.40 | 16.26 | 11.78 | 43.16 | 29.10 | 27.25 |
Forward PE | 16.89 | 12.35 | 10.33 | 12.47 | 37.47 | 14.03 |
PS Ratio | 1.92 | 2.03 | 1.55 | 1.76 | 2.36 | 2.81 |
PB Ratio | 2.46 | 2.60 | 1.96 | 2.54 | 2.20 | 2.18 |
P/TBV Ratio | 2.47 | 2.61 | 1.98 | 2.57 | 2.22 | 2.19 |
P/FCF Ratio | 17.91 | 18.91 | 21.57 | 12.82 | - | 15.67 |
P/OCF Ratio | 12.72 | 13.43 | 9.06 | 7.53 | 53.01 | 11.07 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.17 | 2.25 | 1.85 | 2.13 | 2.69 | 3.12 |
EV/EBITDA Ratio | 7.52 | 7.79 | 6.29 | 7.39 | 11.11 | 11.47 |
EV/EBIT Ratio | 9.57 | 9.91 | 8.17 | 9.93 | 19.02 | 19.20 |
EV/FCF Ratio | 20.20 | 20.91 | 25.79 | 15.48 | - | 17.45 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.39 | 0.39 | 0.48 | 0.55 | 0.53 | 0.26 |
Debt / EBITDA Ratio | 1.06 | 1.06 | 1.28 | 1.32 | 2.37 | 1.22 |
Debt / FCF Ratio | 2.85 | 2.85 | 5.27 | 2.76 | - | 1.85 |
Net Debt / Equity Ratio | 0.31 | 0.31 | 0.30 | 0.48 | 0.48 | 0.22 |
Net Debt / EBITDA Ratio | 0.85 | 0.85 | 0.80 | 1.17 | 2.11 | 1.06 |
Net Debt / FCF Ratio | 2.29 | 2.29 | 3.28 | 2.44 | -4.08 | 1.61 |
Asset Turnover | 0.71 | 0.71 | 0.71 | 0.71 | 0.57 | 0.54 |
Inventory Turnover | 1.33 | 1.33 | 1.37 | 1.31 | 1.19 | 1.09 |
Quick Ratio | 1.08 | 1.08 | 1.02 | 0.68 | 0.95 | 1.70 |
Current Ratio | 2.08 | 2.08 | 1.82 | 1.42 | 1.89 | 3.46 |
Return on Equity (ROE) | 15.98% | 15.98% | 18.41% | 5.60% | 7.37% | 7.77% |
Return on Assets (ROA) | 10.12% | 10.12% | 10.07% | 9.53% | 5.03% | 5.45% |
Return on Invested Capital (ROIC) | 15.77% | 15.88% | 16.49% | 10.03% | 7.58% | 8.40% |
Return on Capital Employed (ROCE) | 23.50% | 23.50% | 22.90% | 24.60% | 10.40% | 10.40% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 6.49% | 6.15% | 8.49% | 2.32% | 3.44% | 3.67% |
FCF Yield | 5.58% | 5.29% | 4.64% | 7.80% | -5.30% | 6.38% |
Dividend Yield | 5.66% | - | 9.10% | - | 7.95% | 7.00% |
Payout Ratio | 98.05% | 98.05% | - | 270.58% | 165.90% | 172.44% |
Total Shareholder Return | 5.66% | - | 9.10% | - | 7.95% | 7.00% |